Jola Mehmeti, PharmD Candidate 2018

Jola Mehmeti, PharmD Candidate 2018
Jola Mehmeti is a final-year PharmD candidate (’18) at the UConn School of Pharmacy. She earned a B.S. in Pharmacy Studies at UConn (’15) and MBA from Sacred Heart University (’17). She is a CITI-certified researcher with investigative and work experience at a large tertiary care center in Hartford, Connecticut. Connect with her on LinkedIn or send a message to contact@jolamehmeti.com.
FDA expands approved indications for ibrutinib in August 2017.
Sep 29, 2017 @04:21 AM
5-Fluorouracil is the mainstay of treatment for many cancers, with upwards of 30% rates of adverse effects. DPD deficiency can further amplify these effects and even lead to life-threatening toxicity. Uridine triacetate is FDA approved for 5-FU and capecitabine overdose treatment within 96 hours of administration.
Sep 21, 2017 @02:05 AM
In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.
Sep 11, 2017 @01:16 AM
How does your pharmacy keep employees happy?
Aug 2, 2016 @08:28 AM
Patients benefit when pharmacists thoroughly assess pain.
Jul 15, 2016 @02:55 AM
Is your organization prepared to handle a cyber attack?
Jun 21, 2016 @03:34 AM
Is diversity a business strategy in your organization?
Jun 14, 2016 @12:23 PM
As the roles of pharmacists expand, so do opportunities for nontraditional practice settings.
Jun 9, 2016 @12:39 PM
Regardless of the outcome, all parties must be prepared to handle the implications of the DEA's decision.
May 31, 2016 @02:12 AM
Once you've decided that you want to participate in research, start early and enter with a goal in mind.
May 23, 2016 @02:49 AM
Transformational leadership may be too much of a good thing.
May 18, 2016 @01:32 AM
The Connecticut General Assembly has voted to expand medical marijuana access to patients younger than 18 years.
May 9, 2016 @08:00 AM
There's a pressing need for patients and health care professionals to quickly recognize and act on the signs of opioid overdose and withdrawal.
Apr 12, 2016 @03:11 AM
Pharmacists must address questions and fears that patients have about the flu vaccine.
Mar 28, 2016 @06:44 AM
Bristol-Myers Squibb recently announced that it's acquiring Padlock Therapeutics, Inc.
Mar 24, 2016 @04:00 AM
One of the most under-recognized and under-addressed barriers to safe and effective care is low vision.
Mar 17, 2016 @09:21 AM
Pharmacokinetic differences in newborns and infants affect drug selection and dosing.
Feb 26, 2016 @02:24 AM
Pharmacists are in pivotal positions to reduce morbidity and lower health costs by assessing and counseling elderly patients at risk for falls.
Feb 2, 2016 @03:28 AM
In a study published in JAMA Internal Medicine, researchers examined whether opioid duration of action is related to risk of unintentional overdose (OD) injury.
Jan 13, 2016 @02:24 AM
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.